- ISIN DE000A11QVV0
- Country Deutschland
Latest Research
News Functions
Additional Functions
7 March 2024
Heidelberg Pharma AG
Original-Research: Heidelberg Pharma AG (von EQUITS GmbH): Kaufen
19 July 2023
Heidelberg Pharma AG
Original-Research: Heidelberg Pharma AG (von EQUITS GmbH): Kaufen
30 April 2020
Heidelberg Pharma AG
Original-Research: HEIDELBERG PHARMA AG (von EQUITS GmbH): Kaufen
27 January 2020
Heidelberg Pharma AG
Original-Research: HEIDELBERG PHARMA AG (von EQUITS GmbH): Kaufen
29 March 2018
Heidelberg Pharma AG
Original-Research: HEIDELBERG PHARMA AG (von EQUITS GmbH): Kaufen
19 May 2017
Heidelberg Pharma AG
Original-Research: WILEX AG (von EQUITS GmbH): Kaufen
Latest News
News Functions
Additional Functions
6 November 2024
Heidelberg Pharma AG
Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024
24 October 2024
Heidelberg Pharma AG
Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024
10 October 2024
Heidelberg Pharma AG
Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
1 October 2024
Heidelberg Pharma AG
Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
Heidelberg Pharma AG
Heidelberg Pharma AG Announces Updated Guidance
23 September 2024
Heidelberg Pharma AG
Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024
Upcoming Events
Latest Reports
News Functions
Additional Functions
10 October 2024
Heidelberg Pharma AG
Q3 statement / Q3 financial report 2023/2024
11 July 2024
Heidelberg Pharma AG
Half-yearly financial report 2023/2024
29 April 2024
Heidelberg Pharma AG
Q1 statement / Q1 financial report 2023/2024
25 April 2024
Heidelberg Pharma AG
Q1 Mitteilung / Q1 Finanzbericht 2023/2024